Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Issue : PJ December 2015 online

Sort by: Newest first Oldest first A-Z Z-A

  • Teratogenic effects with CellCept Subscription

    11 DEC 2015 10:53

    The summaries of product characteristics for CellCept (mycophenolate mofetil; Roche) now state that CellCept should not be inhaled or make direct contact with skin or mucous membranes because of teratogenic effects observed in rats. Additionally, warnings about use in pregnancy have been strengthened.

  • Contraception e-learning Subscription

    11 DEC 2015 10:51

    The Centre for Pharmacy Postgraduate Education (CPPE) has launched a new e-learning programme about contraception. It is available from the CPPE website.

  • Second-generation antidepressants and cognitive behavioural therapy (CBT) are equally effective in patients with depression, researchers have found. In the image, a young girl talks to a therapist

    Talking therapies are just as effective as drugs in depression Subscription

    10 DEC 2015 13:40 By Kirsty Oswald

    Second-generation antidepressants and cognitive behavioural therapy are equally as effective in patients with depression, researchers have found.

  • Treating diabetes patients requires more than drugs Subscription

    10 DEC 2015 13:02 By Monty Goldin

    Pharmacists must realise that type 2 diabetes is not just about glycaemic control. There is more to treating and preventing the condition than throwing pills at patients. Each branch of medicine is now involved in treating type 2 diabetes, including dietitians, dermatologists, podiatrists and even psychiatrists. Do we know the psycho-socioeconomic status of our diabetes patients? Do we understand the ominous octet and the mechanism of gluconeogenesis? It seems we have a lot to learn ...

  • Five out of six women at higher risk of breast cancer decline preventive medication, and those who opt for treatment often fail to take the drugs for long enough to have the full effect. In the image, coloured mammogram of a woman's breast with a tumour

    Most women at risk of breast cancer decline preventive treatment Subscription

    9 DEC 2015 14:13 By Stephen Robinson

    Five out of six women at high risk of breast cancer decline preventive medication, and those who opt for treatment often fail to take the drugs for long enough for them to have the full effect, according to the findings of a meta-analysis.

  • Research found that pre-exposure prophylaxis, taken at the time of sexual activity, reduced the risk of HIV transmission by 86% compared with placebo among men who have sex with men. In the image, close up of Truveda pill used for pre-exposure prophylaxis

    On-demand prophylaxis protects against HIV infection in at-risk men Subscription

    9 DEC 2015 11:12

    Randomised trial shows pre-exposure prophylaxis reduced the risk of HIV transmission by 86%.

  • Extended indication for Opdivo and nivolumab discontinued Subscription

    9 DEC 2015 10:44

    Opdivo (nivolumab; Bristol-Myers Squibb) is now indicated for the treatment of locally advanced or metastatic squamous non-small cell lung cancer after prior chemotherapy in adults, according to the updated summary of product characteristics. Consequently, Nivolumab BMS (nivolumab; Bristol-Myers Squibb) will now be discontinued. Stock of Nivolumab BMS can be exhausted before switching to Opdivo.

  • December 2015: SMC decisions Subscription

    9 DEC 2015 9:32

    The Scottish Medicines Consortium has accepted the following medicines for use in NHS Scotland for particular indications: efavirenz (Sustiva; Bristol-Myers Squibb); glatiramer acetate (Copaxone; Teva); naloxegol (Moventig; AstraZeneca); ceritinib (Zykadia; Novartis).

  • A head-to-head study has found that the capsaicin patch is as effective as pregabalin for peripheral neuropathic pain (PNP). In the image, a woman holds her wrist in pain

    Capsaicin patch as effective as pregabalin for peripheral neuropathic pain Subscription

    8 DEC 2015 16:49

    Head-to-head study shows capsaicin patch is just as effective for peripheral neuropathic pain as standard pregabalin treatment.

  • The curriculum for pharmacy technicians is out of date and needs to change to reflect the increased role they play in community and hospitals, according to a the GPhC. In the image, a pharmacy technician packs a medication bag

    Regulator says curriculum for pharmacy technicians should focus on patient care Subscription

    8 DEC 2015 16:46 By Debbie Andalo

    The curriculum used to train pharmacy technicians is out of date and needs to change to reflect the increased role they play in community and hospitals, according to a review commissioned by the General Pharmaceutical Council. 

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.